Product Information
CHLOROQUINE PH 500 MG TABLET is a generic product labeled by Avet Pharmaceuticals Inc., priced at $6.6539 per EA under NDC 23155085074. Its NADAC has been published 116 times since Jul 17, 2024.
FDA first approved this application on Sep 3, 2021. Its Orange Book therapeutic-equivalence code is AA.
Strength
500 mg/1
Manufacturer
Avet Pharmaceuticals Inc.NDC
23155085074
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHLOROQUINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA214756FDA Approved
9/3/2021
TE Code
AA
On Market Since
3/20/2023
Pharmacological Classes
Price Statistics
The NADAC for CHLOROQUINE PH 500 MG TABLET has been published 116 times since Jul 17, 2024, and over the history we have for it it has risen 30.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6539 per EA |
|---|---|
| All-time high | $6.7412 (Sep 16, 2026) |
| All-time low | $5.0833 (Jul 17, 2024) |
| 52-week high | $6.7412 |
| 52-week low | $5.7554 |
| Median price | $5.7554 |
| Average price | $5.7760 |
| Largest weekly change | +17.1% (Jul 22, 2026) |
| Weeks tracked | 116 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Avet Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chloroquine Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimalarial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLOROQUINE PH 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CHLOROQUINE PH 500 MG TABLET, manufactured by Avet Pharmaceuticals Inc., is $6.6539 per EA (NDC 23155085074), effective Sep 30, 2026.
How has the price of CHLOROQUINE PH 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for CHLOROQUINE PH 500 MG TABLET has risen 30.9%. It has been tracked across 116 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for CHLOROQUINE PH 500 MG TABLET?
Since Jul 17, 2024, the NADAC for CHLOROQUINE PH 500 MG TABLET has ranged from a low of $5.0833 (Jul 17, 2024) to a high of $6.7412 (Sep 16, 2026), with a median of $5.7554 per EA.
Are there cheaper alternatives to CHLOROQUINE PH 500 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CHLOROQUINE PH 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CHLOROQUINE PH 500 MG TABLET?
CHLOROQUINE PH 500 MG TABLET (NDC 23155085074) is labeled by Avet Pharmaceuticals Inc., and CMS classifies it as a generic product.